21128 ⎘
Medicinal preparations containing antigens or antibodies; Viral antigens Adenoviridae
STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT
#2CATIONIC LIPID BASED COMPOSITION, FORMULATION AND USE FOR NUCLEIC ACID VACCINE DELIVERY AND PREPARATION THEREOF
#3NUCLEIC ACIDS ENCODING HUMAN ENDOGENOUS RETROVIRUS K (HERV-K) ENVELOPE PROTEINS CONTAINING MODIFIED IMMUNOSUPPRESSIVE DOMAINS (ISD) AND USES THEREOF
#4PROCESS FOR T CELL EXPANSION
#5PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF
#6COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE
#7RECOMBINANT ADENOVIRUSES AND USES THEREOF
#8STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT
#9VIRUS ENCODING TRANSGENES TO COMPLEMENT CELLULAR THERAPY
#10VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#11NOVEL REOVIRUS-BASED VACCINE PLATFORM AND USE THEREOF
#12GLYCATED CHITOSANS FOR TREATMENT OF VIRAL INFECTIONS
#13FOWL ADENOVIRUS SUBUNIT VACCINE AND PRODUCTION METHOD THEREOF
#14LIPID NANOPARTICLE COMPRISING A NUCLEIC ACID-BINDING PROTEIN
#15Adenoviral Vector
#16Recombinant adenoviruses and uses thereof
#17METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#18NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY
#19Vaccine for use in the prophylaxis and/or treatment of a disease
#20Simian adenoviral vectors with two expression cassettes
#21NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES
#22Vaccine Product
#23Compositions and Methods for Treating Retinal Disorders
#24Biological Therapeutics for Infection-Relating Disorders or Conditions
#25METHOD FOR PURIFYING VIRUS
#26Targeted neoepitope vectors and methods therefor
#27IMMUNOGENIC COMBINATIONS
#28METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#29COMPOUND FOR INCREASING EFFICACY OF VIRAL VECTORS
#30REPLICATION-DEFICIENT ADENOVIRUS
#31Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein
#32VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
#33Coronavirus Vaccine
#34A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#35CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#36Microneedle Array Delivery of Adenovirus Vectored Vaccines With and Without Adjuvants
#37Methods of vaccine administration
#38Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#39Vaccine for use in the prophylaxis and/or treatment of a disease
#40Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#41Vaccine for use in the prophylaxis and/or treatment of a disease
#42BIODEGRADABLE POLYMERIC PARTICLES ENCAPSULATING AN ACTIVE AGENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#43tFIBER PROTEIN FRAGMENT OF AVIAN EGG DROP SYNDROME VIRUS AND VACCINE COMPOSITION PREPARED THEREOF, PREPARATION METHOD AND USE
#44Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#45ANTITUMOR IMMUNITY ENHANCING COMPOSITION CONTAINING ADENOVIRUS SIMULTANEOUSLY EXPRESSING IL-12 AND SHVEGF
#46Adenoviral vector
#47COMBINATION OF A TLR7 MODULATING COMPOUND AND AN HIV VACCINE
#48METHODS OF PRODUCING ADENOVIRUS
#49Vaccines
#50PROCESS FOR T CELL EXPANSION
#51STABILIZED NON-ENVELOPED VIRUS COMPOSITIONS
#52Avian influenza and fowl adenovirus type 4 bi-combined genetic engineering subunit vaccine and method for preparing the same
#53COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY
#54ANTI COVID-19 THERAPIES USING NUCLEOCAPSID AND SPIKE PROTEINS
#55Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses
#56BIOACTIVE VITAMIN COMBINATIONS
#57Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence
#58Rapid and prolonged immunologic-therapeutic
#59COMPOSITION AND METHOD FOR STABILISING VACCINES IN A SOLID DOSAGE FORMAT
#60Simian adenovirus vectors comprising the ChAd-157 fiber protein
#61Adenovirus and uses thereof
#62Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof
#63Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#64Gene Therapy For Mesothelioma
#65COMPOSITIONS AND METHODS FOR COMBINATION CANCER VACCINE AND IMMUNOLOGIC ADJUVANT THERAPY
#66Adeno-associated virus vector
#67Recombinant adenoviruses and uses thereof
#68Antiviral vaccines with improved cellular immunogenicity
#69Compositions and methods for treating retinal disorders
#70METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#71Adenovirus vectors and uses thereof
#72Rapid and prolonged immunogic therapeutic
#73Rapid and prolonged immunologic therapeutic
#74D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation
#75Vaccine for use in the prophylaxis and/or treatment of a disease
#76Adenovirus and uses thereof
#77Methods of vaccine administration
#78SIMIAN ADENOVIRAL VECTORS WITH TWO EXPRESSION CASSETTES
#79Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#80Cell strain for reducing production of replication competent adenovirus, and construction method and use thereof
#81LIVE AND IN-VIVO TUMOR SPECIFIC CANCER VACCINE SYSTEM DEVELOPED BY CO-ADMINISTRATION OF EITHER AT LEAST TWO OR ALL THREE OF THE FOLLOWING COMPONENTS SUCH AS TUMOR CELLS, AN ONCOLYTIC VIRUS VECTOR WITH TRANSGENIC EXPRESSION OF GM-CSF AND AN IMMUNE CHECKPOINT MODULATOR
#82CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors
#83Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#84Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
#85MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen
#86Method for removing anti-AAV antibodies from a blood-derived composition
#87Methods of transfection for large cargo using poly(beta-amino esters)
#88Human Type 14 Replication Defective Adenovirus Vector and Preparation Method for Same and Applications Thereof
#89MODULATION OF TUMOR CELL SUSCEPTIBILITY
#90IMMUNOTHERAPEUTIC PRODUCT AND MDSC MODULATOR COMBINATION THERAPY
#91Antiviral vaccines with improved cellular immunogenicity
#92Biological therapeutics for infection-relating disorders or conditions
#93Re-directed immunotherapy
#94Safe potent single platform vaccine against Tier 1 select agents and other pathogens
#95Vaccines
#96COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY
#97Adenoviral vector
#98COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED DISEASES
#99Process for T cell expansion
#100Enhanced thermal stability for adenoviral vectors through spray drying
#101ANTITUMOR IMMUNITY ENHANCING COMPOSITION CONTAINING ADENOVIRUS SIMULTANEOUSLY EXPRESSING IL-12 AND SHVEGF
#102METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#103Vaccine composition and preparation method and use thereof
#104Composition for preventing or treating keloid or hypertrophic scars
#105Method for enrichment and expansion of virus antigen-specific T cells
#106Novel Prime-Boosting Regimens Involving Immunogenic Polypeptides Encoded by Polynucleotides
#107Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#108Methods and compositions for combination immunotherapy
#109NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS CONTAINING A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) OR FRAGMENT THEREOF
#110Vaccine composition and preparation method and use thereof
#111Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
#112Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
#113Synthetic glucopyranosyl lipid adjuvants
#114Method for preparing antigen-specific cytotoxic T-cells by using activated B-cells and use thereof
#115Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#116LPS vaccine
#117Antiviral vaccines with improved cellular immunogenicity
#118Adjuvant for mucosal vaccine
#119Synthetic glucopyranosyl lipid adjuvants
#120Immunogenic combinations
#121SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#122HPV vaccines and methods of use thereof
#123Breast cancer vaccines and methods of use thereof
#124Prophylactic vaccine against egg drop syndrome (EDS)
#125Cancer Therapy
#126Excipients for stabilising viral particles, polypeptides or biological material
#127Tissue targeted antigenic activation of the immune response to treat cancers
#128REVERSE VACCINATION THERAPY OF MULTIPLE SCLEROSIS
#129LPS VACCINE
#130Dry formulations of vaccines that are room temperature stable
#131Stable aqueous formulations of adenovirus vectors
#132Fowl adenovirus vaccine
#133Fowl adenovirus vaccine
#134Re-directed immunotherapy
#135RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS
#136Biological therapeutics for infection-relating disorders or conditions
#137Antiviral vaccines with improved cellular immunogenicity
#138Immunogenic compositions comprising silicified virus and methods of use
#139SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#140Tissue targeted antigenic activation of the immune response to treat cancers
#141Re-directed immunotherapy
#142Liquid stable virus vaccines
#143NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES
#144LIVE AND IN-VIVO TUMOR SPECIFIC CANCER VACCINE SYSTEM DEVELOPED BY CO-ADMINISTRATION OF EITHER AT LEAST TWO OR ALL THREE OF THE FOLLOWING COMPONENTS SUCH AS TUMOR CELLS, AN ONCOLYTIC VIRUS VECTOR WITH TRANSGENIC EXPRESSION OF GM-CSF AND AN IMMUNE CHECKPOINT MODULATOR
#145Methods of vaccine administration
#146Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#147METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#148LPS vaccine
#149PROCESS FOR T CELL EXPANSION
#150Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#151Stable aqueous formulations of adenovirus vectors
#152Recombinant Trivalent Vaccine Against Human Influenza
#153Synthetic glucopyranosyl lipid adjuvants
#154ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION
#155COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST AVIAN INFECTIOUS BRONCHITIS VIRUS
#156Compositions and methods for the treatment or prevention of human adenovirus-36 infection
#157Liquid stable virus vaccines
#158Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
#159Re-directed immunotherapy
#160Adipogenic Adenoviruses as a Biomarker for Disease
#161Vaccines for inclusion body hepatitis
#162Vaccine Composition
#163Sequential administration of a replication defective adenovirus vector in vaccination protocols
#164FORMULATIONS USEFUL FOR SPRAY DRYING VACCINES
#165Cancer therapy
#166Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#167COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#168Antiviral vaccines with improved cellular immunogenicity
#169Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#170Tissue targeted antigenic activation of the immune response to treat cancers
#171Adipogenic Adenoviruses As A Biomarker For Disease
#172Vaccines for inclusion body hepatitis
#173VACCINE DIRECTED AGAINST ADENOVIRUS SEROTYPE 14
#174NOVEL VACCINE FOR DOG
#175Synthetic glucopyranosyl lipid adjuvants
#176Sequential administration of a replication defective adenovirus vector in vaccination protocols
#177TRANSDERMAL IMMUNE PREPARATION, METHOD FOR PRODUCTION OF THE SAME, AND TRANSDERMAL IMMUNIZATION METHOD USING THE SAME
#178METHODS OF VACCINE ADMINISTRATION
#179CYTOTOXIC T-CELL EPITOPE PEPTIDE AND USE THEREOF
#180Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#181Compositions Comprising a Recombinant Adenovirus and an Adjuvant
#182Compositions comprising viruses and methods for concentrating virus preparations
#183Adipogenic adenoviruses as a biomarker for disease
#184Adipogenic adenoviruses as a biomarker for disease
#185Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor
#186Vaccine For Periodontal Disease
#187COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#188Canine combination vaccines
#189Compositions comprising viruses and methods for concentrating virus preparations
#190CANINE VACCINES
#191Compositions Comprising Viruses and Methods for Concentrating Virus Preparations
#192Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
#193Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#194Compositions comprising viruses and methods for concentrating virus preparations
#195Adipogenic adenoviruses as a biomarker for disease
#196Alkyl-glycoside enhanced vaccination
#197Methods for inducing an immune response via oral administration of an adenovirus
#198Compositions comprising viruses and methods for concentrating virus preparations
#199Compositions comprising viruses and methods for concentrating virus preparations
#200Canine vaccines against Bordetella bronchiseptica
#201Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#202Vaccine for periodontal disease